Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
7.94
+0.23 (2.98%)
Jun 18, 2025, 11:47 AM - Market open
Cybin Market Cap
Cybin has a market cap or net worth of $167.03 million as of June 18, 2025. Its market cap has decreased by -37.15% in one year.
Market Cap
167.03M
Enterprise Value
67.04M
1-Year Change
-37.15%
Ranking
Category
Stock Price
$7.94
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $167.03M, an increase of 83.35%. That is a compound annual growth rate of 14.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 169.13M | -4.13% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |